Bank of Montreal
CBIO

Bank of Montreal’s Crescent Biopharma CBIO Stock Holding History

Bank of Montreal’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Buy
+13,768
New +$269K ﹤0.01% 2878
2021
Q2 		– Sell
-11
Closed -$3K – 4161
2021
Q1 		$3K Sell
11
-47
-81% -$16.8K ﹤0.01% 4817
2020
Q4 		$22K Buy
58
+41
+241% +$14.4K ﹤0.01% 4377
2020
Q3 		$6K Sell
17
-9
-35% -$3.44K ﹤0.01% 4344
2020
Q2 		$10K Buy
+26
New +$7.36K ﹤0.01% 4166
2020
Q1 		– Sell
-74
Closed -$39K – 4318
2019
Q4 		$39K Buy
74
+44
+147% +$23.8K ﹤0.01% 3968
2019
Q3 		$13K Buy
30
+2
+7% +$1.29K ﹤0.01% 4316
2019
Q2 		$33K Buy
+28
New +$33.5K ﹤0.01% 3886
2019
Q1 		– Sell
-5
Closed -$5.72K – 4488
2018
Q4 		$5K Buy
5
+3
+150% +$3.61K ﹤0.01% 4085
2018
Q3 		$3K Sell
2
-50
-96% -$75.6K ﹤0.01% 4233
2018
Q2 		$85K Sell
52
-48
-48% -$82.5K ﹤0.01% 3203
2018
Q1 		$162K Buy
+100
New +$208K ﹤0.01% 2733
2017
Q3 		– Sell
-1
Closed -$1K – 4223
2017
Q2 		$1K Buy
+1
New +$826 ﹤0.01% 4077
2014
Q3 		– Sell
-2
Closed -$2K – 4166
2014
Q2 		$2K Buy
+2
New +$1.99K ﹤0.01% 4490

Other funds holding CBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of Montreal's CBIO Position: Q2 2026 in Review

Bank of Montreal opened a new position in Crescent Biopharma (CBIO) in Q2 2026: 13,768 shares worth $248K. The stake represents ﹤0.01% of the portfolio and ranks #2878 among its holdings. This is a return to the name: Bank of Montreal previously reported a position in CBIO as recently as Q1 2021.

Bank of Montreal first reported a position in CBIO in Q2 2014 and has held it in 14 quarters since. 82 funds tracked by Wall St. Rank hold CBIO as of Q2 2026.

  • Bank of Montreal held 13,768 shares of Crescent Biopharma worth $248K as of Q2 2026.
  • Crescent Biopharma was a new Bank of Montreal position in Q2 2026.
  • Crescent Biopharma made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2878 holding.
  • Bank of Montreal first reported a position in Crescent Biopharma in Q2 2014 and has held it in 14 quarters since.
  • 82 funds tracked by Wall St. Rank held Crescent Biopharma as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.